A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
Heparin/ low molecular weight heparin
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
Novel drug development opportunities for heparin
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
Heparin-induced skin lesions
Heparin/low molecular weight heparin
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
Low-molecular-weight heparin during instability in coronary artery disease
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
